Skip to content
★ Sign in to follow
RE
Total declarations
57
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (14 ops.)
€10.4M

Latest filing published 30 Apr 2021 for Abbott Laboratories.

Filing timeline

BuySale
Robert E. Funck

Insider track record

Disclosed buys
0
Disclosed sells
14
Signal history

Robert E. Funck: trading record in brief

Robert E. Funck is a declared insider of Abbott Laboratories, with filings sourced from SEC (Form 4). We count 57 filings; the first trade dates from 31 January 2014 and the latest from 28 April 2021.

Every open-market trade on record is a sale: 14 sales worth €10.4M. Outside the open market, there are 23 share grants and 16 option exercises.

On 30 April 2021 came the latest disclosure, a transaction in Abbott Laboratories. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Robert E. Funck

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations57 total
  • ●
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    700 shares0Common shares without par valueSEC:0001415889-21-002225:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    1M USD11SEC
    10,136 shares@ US$121.583.5% of flowCommon shares without par valueSEC:0001415889-21-001205:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    24,185 shares0Common shares without par valueSEC:0001415889-21-000892:0
  • ◇
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    1M USD11SEC
    31,325 shares@ US$39.123.5% of flowCommon shares without par valueSEC:0001415889-21-000535:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    2M USD12SEC
    18,241 shares@ US$122.546.5% of flowCommon shares without par valueSEC:0001415889-21-000535:1
  • ●
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    20,000 shares0Common shares without par valueSEC:0001415889-20-002992:0
  • ●
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    10,000 shares0Common shares without par valueSEC:0001415889-20-002992:1
  • ●
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    10,000 shares0Common shares without par valueSEC:0001415889-20-002992:2
  • ◇
    Executive Vice President & CFOExecutivesAbbott Laboratories
    3M USD21SEC
    83,333 shares@ US$38.4018.9% of flowCommon shares without par valueSEC:0001179110-20-010699:0
  • ▼
    Executive Vice President & CFOExecutivesAbbott Laboratories
    9M USD36SEC
    83,333 shares@ US$108.827953.5% of flowCommon shares without par valueSEC:0001179110-20-010699:1
  • ◇
    Executive Vice President & CFOExecutivesAbbott Laboratories
    828,078 USD20SEC
    23,700 shares@ US$34.945.3% of flowCommon shares without par valueSEC:0001179110-20-005068:0
  • ◇
    Executive Vice President & CFOExecutivesAbbott Laboratories
    508,560 USD19SEC
    13,000 shares@ US$39.123.3% of flowCommon shares without par valueSEC:0001179110-20-005068:1
  • ◆
    Executive Vice President & CFOExecutivesAbbott Laboratories
    2M USD21SEC
    23,855 shares@ US$98.0015.0% of flowCommon shares without par valueSEC:0001179110-20-005068:2
  • ◆
    Executive Vice President & CFOExecutivesAbbott Laboratories
    531,365 USD19SEC
    6,710 shares@ US$79.192.7% of flowCommon shares without par valueSEC:0001179110-20-002920:0
  • ▼
    Executive Vice President & CFOExecutivesAbbott Laboratories
    105,619 USD37SEC
    1,356 shares@ US$77.890.5% of flowCommon shares without par valueSEC:0001179110-20-002920:1
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    0SEC
    25,265 shares0Common shares without par valueSEC:0001179110-20-002264:0
  • ◇
    Senior Vice PresidentExecutivesAbbott Laboratories
    1M USD12SEC
    40,000 shares@ US$34.946.0% of flowCommon shares without par valueSEC:0001179110-19-009489:0
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    2M USD12SEC
    26,818 shares@ US$85.569.8% of flowCommon shares without par valueSEC:0001179110-19-009489:1
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    361,436 USD11SEC
    4,680 shares@ US$77.231.5% of flowCommon shares without par valueSEC:0001179110-19-003116:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    78,156 USD29SEC
    1,002 shares@ US$78.000.3% of flowCommon shares without par valueSEC:0001179110-19-003116:1
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    0SEC
    23,344 shares0Common shares without par valueSEC:0001179110-19-002641:0
  • ◇
    Senior Vice PresidentExecutivesAbbott Laboratories
    254,043 USD11SEC
    9,700 shares@ US$26.191.0% of flowCommon shares without par valueSEC:0001179110-18-011220:0
  • ◇
    Senior Vice PresidentExecutivesAbbott Laboratories
    275,397 USD11SEC
    12,300 shares@ US$22.391.1% of flowCommon shares without par valueSEC:0001179110-18-011220:1
  • ◇
    Senior Vice PresidentExecutivesAbbott Laboratories
    389,232 USD11SEC
    14,400 shares@ US$27.031.6% of flowCommon shares without par valueSEC:0001179110-18-011220:2
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    2M USD12SEC
    23,751 shares@ US$67.116.5% of flowCommon shares without par valueSEC:0001179110-18-011220:3

25 of 57 declarations